{
    "organizations": [],
    "uuid": "1d05fa610ae8d14fbac9968c7bc44b5cf8c2f539",
    "author": "",
    "url": "https://www.reuters.com/article/brief-mylan-biocon-seek-to-accelerate-in/brief-mylan-biocon-seek-to-accelerate-introduction-of-adalimumab-biosimilar-in-eu-idUSFWN1RO0GL",
    "ord_in_thread": 0,
    "title": "BRIEF-Mylan, Biocon Seek To Accelerate Introduction Of Adalimumab Biosimilar In EU",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 24 AM / Updated 18 minutes ago BRIEF-Mylan, Biocon Seek To Accelerate Introduction Of Adalimumab Biosimilar In EU Reuters Staff 1 Min Read \nApril 11 (Reuters) - Biocon Ltd: \n* MYLAN, BIOCON SEEK TO ACCELERATE INTRODUCTION OF ADALIMUMAB BIOSIMILAR IN EU Source text - bit.ly/2IIPzM6 Further company coverage:",
    "published": "2018-04-11T14:23:00.000+03:00",
    "crawled": "2018-04-11T14:47:45.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "biocon",
        "seek",
        "accelerate",
        "introduction",
        "adalimumab",
        "biosimilar",
        "eu",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "biocon",
        "ltd",
        "mylan",
        "biocon",
        "seek",
        "accelerate",
        "introduction",
        "adalimumab",
        "biosimilar",
        "eu",
        "source",
        "text",
        "company",
        "coverage"
    ]
}